Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol and Etodolac for Colorectal Cancer Surgery
NCT00888797Phase 3Unknown
- Sponsor
- Sheba Medical Center
- Start
- Jan 2010
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of propranolol, etodolac in colorectal cancer (CRC), sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
propranololetodolac
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00888797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00888797.